Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $337.54. The company's market cap stands at 181.71B, with a P/E ratio of 26.09 and a dividend yield of 2.8%.
On 2025-11-22, Amgen(AMGN) stock moved within a range of $334.74 to $342.84. With shares now at $337.54, the stock is trading +0.8% above its intraday low and -1.5% below the session's peak.
Trading activity shows a volume of 4.09M, compared to an average daily volume of 3.07M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $345.84 and a low of $253.30.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $345.84 and a low of $253.30.
AMGN News
Insiders have been trading these 5 stocks: ((TEVA)), ((AMGN)), ((RITM)), ((FSLY)) and ((MDT)). Here is a breakdown of their recent trades and their value. TipR...
Blue Chips, Value-Oriented Firms Reign Over Market Gains; Is Leadership's Complexion Changing? 11/11/2025 Amgen's riveting 14% gain over five sessions stands i...
In early trading on Thursday, shares of Walmart topped the list of the day's best performing Dow Jones Industrial Average components, trading up 4.4%. Year to d...
Analyst ratings
47%
of 34 ratingsMore AMGN News
We wouldn't blame Amgen Inc. ( ) shareholders if they were a little worried about the fact that Murdo Gordon, the Executive Vice President of Global Commercial...
(RTTNews) - Amgen (AMGN) announced that the U.S. Food and Drug Administration has granted full approval to IMDELLTRA (tarlatamab-dlle) for the treatment of adul...
Amgen (AMGN) announced that the U.S. FDA has granted full approval to IMDELLTRA for the treatment of adult patients with extensive stage small cell lung cancer...
Looking at the universe of stocks we cover at Dividend Channel, on 11/21/25, NextEra Energy Inc (Symbol: NEE), Amgen Inc (Symbol: AMGN), and CRH plc (Symbol: CR...
Amgen (AMGN) shares have delivered a 16% return over the past three months, catching the attention of investors interested in steady growth. The company's recen...
Earlier this month, Amgen announced detailed results from its Phase 3 VESALIUS-CV clinical trial, showing that Repatha® (evolocumab) achieved statistically sign...
In early trading on Monday, shares of Amgen topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date,...